Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.

ABSTRACT:

Importance

Prostate-specific antigen (PSA) screening for prostate cancer is controversial but may be associated with benefit for certain high-risk groups.

Objectives

To evaluate associations of county-level PSA screening prevalence with prostate cancer outcomes, as well as variation by sociodemographic and clinical factors.

Design, setting, and participants

This cohort study used data from cancer registries based in 8 US states on Hispanic, non-Hispanic Black, and non-Hispanic White men aged 40 to 99 years who received a diagnosis of prostate cancer between January 1, 2000, and December 31, 2015. Participants were followed up until death or censored after 10 years or December 31, 2018, whichever end point came first. Data were analyzed between September 2023 and Janua

SUBMITTER: Iyer HS 

PROVIDER: S-EPMC11151156 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature